These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

748 related items for PubMed ID: 11129646

  • 1. DNA vaccination: antigen presentation and the induction of immunity.
    Shedlock DJ, Weiner DB.
    J Leukoc Biol; 2000 Dec; 68(6):793-806. PubMed ID: 11129646
    [Abstract] [Full Text] [Related]

  • 2. DNA vaccines--challenges in delivery.
    Pachuk CJ, McCallus DE, Weiner DB, Satishchandran C.
    Curr Opin Mol Ther; 2000 Apr; 2(2):188-98. PubMed ID: 11249641
    [Abstract] [Full Text] [Related]

  • 3. New tools for antigen delivery to the MHC class I pathway.
    Morón G, Dadaglio G, Leclerc C.
    Trends Immunol; 2004 Feb; 25(2):92-7. PubMed ID: 15102368
    [Abstract] [Full Text] [Related]

  • 4. Targeting dendritic cells to enhance DNA vaccine potency.
    You Z, Huang X, Hester J, Toh HC, Chen SY.
    Cancer Res; 2001 May 01; 61(9):3704-11. PubMed ID: 11325842
    [Abstract] [Full Text] [Related]

  • 5. Modifying professional antigen-presenting cells to enhance DNA vaccine potency.
    Hung CF, Yang M, Wu TC.
    Methods Mol Med; 2006 May 01; 127():199-220. PubMed ID: 16988456
    [Abstract] [Full Text] [Related]

  • 6. Genetically modified tumour vaccines--where we are today.
    Nawrocki S, Mackiewicz A.
    Cancer Treat Rev; 1999 Feb 01; 25(1):29-46. PubMed ID: 10212588
    [Abstract] [Full Text] [Related]

  • 7. Virosomes for antigen and DNA delivery.
    Daemen T, de Mare A, Bungener L, de Jonge J, Huckriede A, Wilschut J.
    Adv Drug Deliv Rev; 2005 Jan 10; 57(3):451-63. PubMed ID: 15560951
    [Abstract] [Full Text] [Related]

  • 8. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 10; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 9. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C, Rogers WO, Gowda K, Doolan DL.
    Immunol Lett; 2007 Aug 15; 111(2):92-102. PubMed ID: 17604849
    [Abstract] [Full Text] [Related]

  • 10. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC, Anderson E, Bootland LM, Chiou PW, Johnson M, Kim C, Mourich D, Trobridge G.
    Dev Biol Stand; 1997 Aug 15; 90():267-77. PubMed ID: 9270855
    [Abstract] [Full Text] [Related]

  • 11. The processing of antigens delivered as DNA vaccines.
    Howarth M, Elliott T.
    Immunol Rev; 2004 Jun 15; 199():27-39. PubMed ID: 15233724
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Improving DNA vaccine potency via modification of professional antigen presenting cells.
    Hung CF, Wu TC.
    Curr Opin Mol Ther; 2003 Feb 15; 5(1):20-4. PubMed ID: 12669466
    [Abstract] [Full Text] [Related]

  • 14. DNA vaccine encoding endosome-targeted human papillomavirus type 16 E7 protein generates CD4+ T cell-dependent protection.
    Brulet JM, Maudoux F, Thomas S, Thielemans K, Burny A, Leo O, Bex F, Hallez S.
    Eur J Immunol; 2007 Feb 15; 37(2):376-84. PubMed ID: 17274002
    [Abstract] [Full Text] [Related]

  • 15. DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma.
    Sloots A, Mastini C, Rohrbach F, Weth R, Curcio C, Burkhardt U, Jäger E, Forni G, Cavallo F, Wels WS.
    Clin Cancer Res; 2008 Nov 01; 14(21):6933-43. PubMed ID: 18980988
    [Abstract] [Full Text] [Related]

  • 16. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
    Teramoto K, Kontani K, Ozaki Y, Sawai S, Tezuka N, Nagata T, Fujino S, Itoh Y, Taguchi O, Koide Y, Asai T, Ohkubo I, Ogasawara K.
    Cancer Res; 2003 Nov 15; 63(22):7920-5. PubMed ID: 14633722
    [Abstract] [Full Text] [Related]

  • 17. Modulating the immune response to genetic immunization.
    Cohen AD, Boyer JD, Weiner DB.
    FASEB J; 1998 Dec 15; 12(15):1611-26. PubMed ID: 9837851
    [Abstract] [Full Text] [Related]

  • 18. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR, Holst PJ, Pircher H, Christensen JP, Thomsen AR.
    Eur J Immunol; 2009 Oct 15; 39(10):2725-36. PubMed ID: 19637230
    [Abstract] [Full Text] [Related]

  • 19. Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy.
    Bodey B, Siegel SE, Kaiser HE.
    In Vivo; 2004 Oct 15; 18(1):81-100. PubMed ID: 15011756
    [Abstract] [Full Text] [Related]

  • 20. DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells.
    Fredriksen AB, Sandlie I, Bogen B.
    Mol Ther; 2006 Apr 15; 13(4):776-85. PubMed ID: 16414309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.